Blue Sphere Health


Bluesphere’s innovative “software + consulting” approach, including our structured DRASTIC™ approach to brand protection strategy, has been used to help a number of companies to protect their products more successfully. We consult for pharmaceutical, medical device, food and beverage companies of all sizes from global multi-national to small and mid-sized companies (SMEs). As well as working with manufacturers and market authorisation holders, we advise distributors, contract manufacturers, technology vendors, investors and other entities with an interest in supply chain security. We also help brand owners to manage their incident identification and reporting workload with innovative software products.

US top-25 pharma

Using UK and US-based consultants, we developed and helped implement a global brand protection strategy. This involved devising a rigorous risk assessment procedure to enable prioritization of activities across the product portfolio. We also performed a multi-site process mapping exercise to identify key brand protection touch-points and gaps. We then worked with our customer’s manufacturing sites and the HQ team in designing a robust technology selection and artwork management process for packaging security features.

European mid-sized specialty pharma

We helped a >EUR 1 billion company to examine its product protection strategy from first principles. The first stage was an examination of the As-Is situation, gathering information on our client’s eleven production lines at six sites around the world. We also examined the state of readiness of their external Contract Manufacturer Organisation (CMO) network. Based on our client’s exposure to global compliance requirements, and our joint assessment of their likely counterfeiting risks, we made a recommendation of a To-Be scenario. Finally, we conducted a Gap Analysis between the two and proposed a strategy and draft timeline. Working on a tight deadline, we got the exercise completed in less than three months. Outputs were used to plan capital acquisition requests for major investments in new line equipment.

Your company

Don’t try to solve brand protection problems on your own. Contact Bluesphere for whatever level of support you need, from filling a short term resource gap to designing a multi-million dollar programme. As well as providing our own dashboard and management tools, we also advise on technology choices in other areas such as packaging features. We can even manage the vendor selection process for you.

Contact Us

Your Name (required)

Your Email (required)


Your Message

Pharmaceutical Anti-Counterfeiting

Combating the Real Danger from Fake Drugs has become a must-have primer on anti-counterfeiting and is widely used by drug companies, regulators and others. The book covers the legal, strategic and political issues as well as the technical counter-measures such as process control, digital serialisation and physical security.

Pharmaceutical Anti-Counterfeiting book